(31) also presented that the expression levels of CXCL2 (p = 0.001) and CXCL9 (p = 6.21E−4) in pancreatic ductal adenocarcinoma significantly increased. This evidence concerns the gene CXCL9 and pancreatic ductal adenocarcinoma.